Gilead

Knowledge Ecology International asks US Federal Trade Commission to Investigate Gilead Effort to Control Market for AIDS Drugs Ingredients

KEI Documents

February 12, 2007. Complaint. KEI request for investigation into anticompetitive aspects of Gilead Voluntary Licenses for patents on Tenofovir and Emtricitabine

February 12, 2007. Press Release. FTC Asked to Investigate Gilead Effort to Control Market for AIDS Drugs Ingredients.

Industry Documents

September 22, 2006. Gilead Press Release. Gilead Announces Licensing Agreements with Eight India-Based Companies for Manufacturing and Distribution of Generic Versions Of Viread in the Developing World.

September 22, 2006. Ranbaxy Press Release. Ranbaxy in Pact with Gilead Sciences Anti-HIV Drug Tenofovir.

News Stories and Blogs

February 16, 2007. FDA News. Group Questions Gilead's HIV Drug Licenses.

February 15, 2007. Ed Silverman in Pharmalot. Gilead Unfairly Controls AIDS Ingredients.

September 26, 2006. Gregory Roumeliotis for In-Pharma Technologist. Gilead rains manufacturing deals on India's generic firms.

Controversy Over the Lack of Tenofovir Registration in Developing Countries

MSF Documents

February 7, 2006. Press Release. Gilead's Tenofovir 'Access Program' for Developing Countries: A Case of False Promises?

February 7, 2006. Briefing Paper. Gilead's Tenofovir 'Access Program' For Developing Countries.

News Stories and Blogs

February 17, 2006. Daniel S. Levine for the San Francisco Business Times. Gilead takes heat over efforts to provide AIDS drug for poor.

February 7, 2006. Paul Elias for the Associated Press. Biotech company Gilead criticized for AIDS drug supply.

February 7, 2006. Carey Sargent for Bloomberg. Gilead's Viread Unavailable in Developing Countries.

Miscellaneous Information on Gilead

Gilead.com

Gilead Access Program for Truvada and Viread

Gilead's SEC 10-K for Year Ended December 31, 2005.